Who owns Vertex Pharmaceuticals Incorporated?

Key details on Vertex Pharmaceuticals Incorporated (Ticker: VRTX)

Who owns Vertex Pharmaceuticals Incorporated?

Is VRTX a good stock to own? Find out who bought Vertex Pharmaceuticals Incorporated, who sold Vertex Pharmaceuticals Incorporated (VRTX) stock, and who holds a large position in Vertex Pharmaceuticals Incorporated.

Fund Name Number of Shares Share Valuation As Of
Capital World Investors^ 24.61M $2.92B Dec. 31, 2014
Wellington Management Company 17.19M $2.04B Dec. 31, 2014
Vanguard 15.50M $1.84B Dec. 31, 2014
FMR 14.02M $1.57B Sept. 30, 2014
T. Rowe Price Associates 13.29M $1.58B Dec. 31, 2014
JPMORGAN CHASE & CO 10.43M $1.24B Dec. 31, 2014
STATE STREET CORPORATION 10.26M $1.22B Dec. 31, 2014
Ameriprise Financial 9.31M $1.11B Dec. 31, 2014
ClearBridge Advisors 7.52M $893.81M Dec. 31, 2014
Jennison Associates 6.71M $796.64M Dec. 31, 2014
BlackRock Institutional Trust Company, N.A. 6.32M $750.34M Dec. 31, 2014
BlackRock Fund Advisors 5.79M $687.76M Dec. 31, 2014
Westfield Capital Management Company 5.55M $184.31M Dec. 31, 2011
Janus Capital Management 5.09M $405.72M June 30, 2013
Lazard Asset Management 4.89M $204.96M Dec. 31, 2012
GOLDMAN SACHS 4.60M $325.31M March 31, 2014

Who sold Vertex Pharmaceuticals Incorporated?

Fund Name Date Sold Number of Shares Sold Share Valuation
Brookside Capital Management, LLC* Sept. 30, 2011 5.19M $230.74M
Waddell & Reed Financial Sept. 30, 2011 4.83M $215.10M
D. E. Shaw & Co Dec. 31, 2010 7.48M $262.12M
ALLIANCEBERNSTEIN Dec. 31, 2010 5.36M $187.85M
BB Biotech AG Dec. 31, 2010 5.02M $175.76M